Licensed Anti-Microbial Drugs Logical for Clinical Trials against Pathogens Currently Suspected in Alzheimer’s Disease
Open Access
- 20 March 2021
- journal article
- research article
- Published by MDPI AG in Antibiotics
- Vol. 10 (3) , 327
Abstract
There is now considerable evidence that several infectious agents (viruses, bacteria, or parasites) may play a contributing role in the development of Alzheimer’s disease (AD). The six primary suspects are herpes viruses, spirochetal bacteria, Chlamydia pneumoniae, Porphyromonas gingivalis, mycobacteria, and toxoplasma parasites. Also, some of the antimicrobial and antiviral agents that are used to treat them have shown promise for AD interventions. I describe this evidence and assert it is now time to accelerate clinical trials of these existing drugs, already federally approved, to determine if such treatments can delay, halt, or reverse AD.Keywords
All Related Versions
This publication has 52 references indexed in Scilit:
- Apolipoprotein E isoforms and regulation of the innate immune response in brain of patients with Alzheimer's diseaseCurrent Opinion in Neurobiology, 2011
- Inflammation in Alzheimer Disease--A Brief Review of the Basic Science and Clinical LiteratureCold Spring Harbor Perspectives in Medicine, 2011
- Antivirals Reduce the Formation of Key Alzheimer's Disease Molecules in Cell Cultures Acutely Infected with Herpes Simplex Virus Type 1PLOS ONE, 2011
- Amyloid-β and tau — a toxic pas de deux in Alzheimer's diseaseNature Reviews Neuroscience, 2010
- Acyclovir or Aβ42 peptides attenuate HSV-1-induced miRNA-146a levels in human primary brain cellsNeuroReport, 2010
- Immunohistological detection of Chlamydia pneumoniae in the Alzheimer's disease brainBMC Neuroscience, 2010
- The Alzheimer's Disease-Associated Amyloid β-Protein Is an Antimicrobial PeptidePLOS ONE, 2010
- Periodontitis is associated with cognitive impairment among older adults: analysis of NHANES-IIIJournal of Neurology, Neurosurgery & Psychiatry, 2009
- Beta-amyloid deposition and Alzheimer's type changes induced by Borrelia spirochetesNeurobiology of Aging, 2006
- Rifampicin Prevents the Aggregation and Neurotoxicity of Amyloid β Protein in VitroBiochemical and Biophysical Research Communications, 1994